REQUEST A DEMO
Total
USD $0.00
Search more companies

Co Re Na Ecza Deposu Dis Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Co Re Na Ecza Deposu Dis Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Chesterfield-Ruby Middle School is a pharmaceutical and healthcare products provider. The company specializes in the supply and distribution of pharmaceutical products, medical consumables, and wellness solutions. With a team of professionals, they offer distribution and supply services for healthcare products to pharmacies, doctors, hospitals, clinics, and government agencies in more than 137 countries. Chesterfield-Ruby Middle School claims to have a global presence and experience necessary to diverse healthcare needs and claims to be dedicated to delivering essential healthcare solutions to individuals and communities worldwide. They have been supplying comparator drugs and reference products since 2004 and have been awarded the title of the leading exporter in the pharmaceutical industry in Turkey.

Headquarters
No:14 A-1 Umit Mahallesi 2545 Sokak Cankaya
Ankara; Central Anatolia; Postal Code: 06810

Contact Details: Purchase the Co Re Na Ecza Deposu Dis Ticaret A.S. report to view the information.

Website: http://www.corena.com.tr

Basic Information
Total Employees:
Purchase the Co Re Na Ecza Deposu Dis Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Co Re Na Ecza Deposu Dis Ticaret A.S. report to view the information.
Incorporation Date:
April 28, 2006
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Co Re Na Ecza Deposu Dis Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
96.42%
Total operating revenue
96.42%
Operating profit (EBIT)
136.02%
Net Profit (Loss) for the Period
129.78%
Total assets
95.85%
Total equity
72.56%
Operating Profit Margin (ROS)
1.25%
Net Profit Margin
0.92%
Return on Equity (ROE)
9.87%
Debt to Equity Ratio
41.14%
Quick Ratio
-0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?